Exercise Training for Patients with Chronic Lymphocytic Leukaemia
Author Information
Author(s): Frankie F. Brown, Rebecca Oliver, Rachel Eddy, Adam J. Causer, Annabelle Emery, Harrison D. Collier-Bain, David Dutton, Josephine Crowe, Daniel Augustine, John Graby, Daniel Rees, Daniela Rothschild-Rodriguez, Oliver J. Peacock, Sally Moore, James Murray, James E. Turner, John P. Campbell
Primary Institution: Department for Health, University of Bath, Bath, United Kingdom
Hypothesis
Can a 16-week exercise program improve health outcomes in treatment-naïve chronic lymphocytic leukaemia (CLL) patients?
Conclusion
The exercise training program was feasible and safe for treatment-naïve CLL patients, resulting in an increase in lean mass but no significant changes in disease activity.
Supporting Evidence
- Trial uptake was 40%, with an overall retention rate of 86%.
- Adherence to the exercise intervention was 92 ± 8%.
- One serious adverse event was reported unrelated to the trial.
- The exercise intervention resulted in a 2% increase in lean mass in the exercise group.
Takeaway
This study showed that doing exercise can help people with a type of blood cancer called CLL gain muscle without making their cancer worse.
Methodology
40 treatment-naïve CLL patients were randomized into an exercise group or a control group, with outcomes measured before and after a 16-week intervention.
Potential Biases
Potential selection bias due to the voluntary nature of participation.
Limitations
The study duration was short, and the exercise intensity may not have been sufficient to improve cardiorespiratory fitness.
Participant Demographics
Mean age of participants was 62 years, with a mix of genders.
Statistical Information
P-Value
0.01
Statistical Significance
p = 0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website